405 related articles for article (PubMed ID: 31980023)
1. Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy.
Zhong X; Zhang H; Zhu Y; Liang Y; Yuan Z; Li J; Li J; Li X; Jia Y; He T; Zhu J; Sun Y; Jiang W; Zhang H; Wang C; Ke Z
Mol Cancer; 2020 Jan; 19(1):15. PubMed ID: 31980023
[TBL] [Abstract][Full Text] [Related]
2. Profiling circulating tumour cells and other biomarkers of invasive cancers.
Poudineh M; Sargent EH; Pantel K; Kelley SO
Nat Biomed Eng; 2018 Feb; 2(2):72-84. PubMed ID: 31015625
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of circulating tumor cells in immunotherapy.
Rzhevskiy A; Kapitannikova A; Malinina P; Volovetsky A; Aboulkheyr Es H; Kulasinghe A; Thiery JP; Maslennikova A; Zvyagin AV; Ebrahimi Warkiani M
Theranostics; 2021; 11(16):8057-8075. PubMed ID: 34335980
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
[TBL] [Abstract][Full Text] [Related]
5. The biology and clinical potential of circulating tumor cells.
Lozar T; Gersak K; Cemazar M; Kuhar CG; Jesenko T
Radiol Oncol; 2019 May; 53(2):131-147. PubMed ID: 31104002
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological significance of circulating tumor cells in cancer.
Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
[TBL] [Abstract][Full Text] [Related]
7. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
[TBL] [Abstract][Full Text] [Related]
9. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents.
Garrido-Navas C; de Miguel-Perez D; Exposito-Hernandez J; Bayarri C; Amezcua V; Ortigosa A; Valdivia J; Guerrero R; Garcia Puche JL; Lorente JA; Serrano MJ
Cells; 2019 Nov; 8(11):. PubMed ID: 31684193
[TBL] [Abstract][Full Text] [Related]
10. Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases.
Mamdouhi T; Twomey JD; McSweeney KM; Zhang B
Cancer Metastasis Rev; 2019 Jun; 38(1-2):297-305. PubMed ID: 31053984
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells: a multifunctional biomarker.
Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of circulating tumor cells-from bench to bedside.
Li Y; Wu S; Bai F
Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.
Agarwal A; Balic M; El-Ashry D; Cote RJ
Cancer J; 2018; 24(2):70-77. PubMed ID: 29601333
[TBL] [Abstract][Full Text] [Related]
14. Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots.
Kuo CW; Chueh DY; Chen P
J Nanobiotechnology; 2019 Feb; 17(1):26. PubMed ID: 30728024
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells: biology and clinical significance.
Lin D; Shen L; Luo M; Zhang K; Li J; Yang Q; Zhu F; Zhou D; Zheng S; Chen Y; Zhou J
Signal Transduct Target Ther; 2021 Nov; 6(1):404. PubMed ID: 34803167
[TBL] [Abstract][Full Text] [Related]
16. Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer.
Chalfin HJ; Pramparo T; Mortazavi A; Niglio SA; Schonhoft JD; Jendrisak A; Chu YL; Richardson R; Krupa R; Anderson AKL; Wang Y; Dittamore R; Pal SK; Lara PN; Stein MN; Quinn DI; Steinberg SM; Cordes LM; Ley L; Mallek M; Sierra Ortiz O; Costello R; Cadena J; Diaz C; Gulley JL; Dahut WL; Streicher H; Wright JJ; Trepel JB; Bottaro DP; Apolo AB
Clin Cancer Res; 2021 Mar; 27(5):1391-1398. PubMed ID: 33262136
[TBL] [Abstract][Full Text] [Related]
17. Utilizing Matrigel Transwell Invasion Assay to Detect and Enumerate Circulating Tumor Cells.
Liu X; Wu X
Methods Mol Biol; 2017; 1634():277-282. PubMed ID: 28819859
[TBL] [Abstract][Full Text] [Related]
18. Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives.
Wu T; Cheng B; Fu L
Mol Pharmacol; 2017 Sep; 92(3):232-239. PubMed ID: 28356334
[TBL] [Abstract][Full Text] [Related]
19. Survival Mechanisms and Influence Factors of Circulating Tumor Cells.
Wang WC; Zhang XF; Peng J; Li XF; Wang AL; Bie YQ; Shi LH; Lin MB; Zhang XF
Biomed Res Int; 2018; 2018():6304701. PubMed ID: 30515411
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients.
Ortiz-Otero N; Marshall JR; Lash B; King MR
BMC Cancer; 2020 Sep; 20(1):873. PubMed ID: 32917154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
